← Back to all trials
Completed
NCT07167069
India HIV-CervCa Project
Conditions: HIV Positive, HIV Negative, Cervical Cancer
Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 180
Sponsor: Abramson Cancer Center at Penn Medicine
Location: Tata Memorial Hospital Mumbai Maharashtra
Summary
The investigators propose to prospectively study the difference in treatment (CTRT) completion and toxicities between HIV positive and HIV negative women in India with locally advanced cervical cancer receiving CTRT.
Eligibility Criteria
Inclusion Criteria:
* patients with newly biopsy proven squamous carcinoma or adenocarcinoma of the uterine cervix, FIGO stage IB2-IIIB in whom curative CTRT is planned
* Karnofsky performance status ≥ 70
* Patients with lower paraortic lymph nodes (below the level of L2 vertebra)
* patients diagnosed with cervical cancer whom also HIV positive or HIV negative
Exclusion Criteria:
* patients with active tuberculosis
Source: ClinicalTrials.gov (NCT07167069). StuddyBuddy aggregates publicly available trial information.
